Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
Medicover
OM:MCOV B Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
Medicover
Popular
Undervalued
Overvalued
Medicover
WA
Analyst Price Target
Consensus Narrative from 6 Analysts
New Investments In India's And Romania's Healthcare Services Will Expand Future Global Reach
Key Takeaways Strong cash generation supports debt reduction and further investments, boosting future earnings growth positively. Strategic initiatives in Germany aim to enhance efficiency, mitigating pricing pressures and supporting margin expansion and earnings.
View narrative
SEK 214.61
FV
6.1% undervalued
intrinsic discount
13.05%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Your Valuation for
MCOV B
Medicover
Your Fair Value
SEK
Current Price
SEK 201.50
25.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue €3.6b
Earnings €29.1m
Advanced
Set as Fair Value